BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
48 hedge funds and large institutions have $182M invested in BELLUS Health Inc. in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.
33% more capital invested
Capital invested by funds: $137M → $182M (+$44.9M)
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
4% more funds holding
Funds holding: 46 → 48 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
+$10.7M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.31M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.07M |
| 4 |
TLP
Tri Locum Partners
New York
|
+$1.44M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
-$4.71M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.87M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.59M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.51M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACI
51
AMP Capital Investors
Sydney,
Australia
| – | -$116K | -38,900 | Closed |
|
52
Jane Street
New York
| – | -$98K | -32,470 | Closed |
|
|
SSA
53
Schonfeld Strategic Advisors
New York
| – | -$49K | -16,400 | Closed |
|
54
D.E. Shaw & Co
New York
| – | -$32K | -10,452 | Closed |
|
55
BlackRock
New York
| – | -$15K | -3,965 | -100% |
|
56
Osaic Holdings
Scottsdale,
Arizona
| – | -$3K | -700 | Closed |
|
57
Simplex Trading
Chicago,
Illinois
| – | +$3.61K | +951 | New |
|
BLU Hedge Fund Activity: Q1 2021 in Review
48 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q1 2021, worth a combined $182M — up 33% from $137M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BLU positions and 10 closed out — a net gain of 2 holders — while 9 added to existing stakes and 13 trimmed.
The largest buyer was Laurion Capital Management, adding an estimated $10.7M. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $4.71M sold.
- 48 institutional investors held BELLUS Health Inc. (BLU) as of Q1 2021, up from 46 in Q4 2020.
- Funds reported $182M of BELLUS Health Inc. stock for Q1 2021, up 33% quarter-over-quarter.
- 12 funds opened new BELLUS Health Inc. positions in Q1 2021 and 10 closed out, a net change of +2 holders.
- The largest BELLUS Health Inc. buyer in Q1 2021 was Laurion Capital Management, an estimated $10.7M added.
- The largest BELLUS Health Inc. seller in Q1 2021 was Suvretta Capital Management, an estimated $4.71M sold.
Based on aggregated 13F filings for Q1 2021.